Apotex to pay $24.1 million for fixing pravastatin prices

The Department of Justice has settled claims accusing Apotex of fixing the price of the generic drug pravastatin. The Florida-based company will pay a $24.1 million criminal fine....

Subscription required to view this article.

This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content

If you do not currently subscribe to FTCWatch please contact us for subscription information:
Email: customerservices@mlex.com

FTCWatch is delivered in the following formats: via email alert and online at mlexwatch.com/ftcwatch